packageMecaserminRinfabate

mecasermin rinfabate

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Mecasermin rinfabate, a combination of insulin-like growth factor-I and its binding protein, was developed as a growth-related treatment for pituitary dwarfism. Its marketing application in the European Union was withdrawn, and it remains listed as approved and investigational elsewhere.

Summary written by glm-5.3-flash from Wikidata Q6804391 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:mecasermin rinfabate
ATC codes:H01AC05
DrugBank:DB14751
Wikidata:Q6804391

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown